Mixed earnings results from the German Bayer Group put the pharmaceutical giant’s share prices on a rollercoaster ride in Tuesday’s early trading.
Trending
- Medical neglect contributed to mother's death, inquest finds
- Why Iran’s Nuclear Program Isn’t the Only Threat
- Early SpaceX backer funds UK satellite data start-up | Money News
- Russia moves to block WhatsApp in messaging app crackdown
- ‘Tipping point’ reached in creation of brain chips to help ‘unlock’ minds of people with paralysis | Science, Climate & Tech News
- Instagram boss: 16 hours of daily use is 'problematic,' not addiction
- Laboratoria vinden nog veel meer asbest in speelgoed, ook in ‘magisch’ speelzand
- Researchers turn to UK archive to solve under-50s bowel cancer mystery
